New Ideal - Reason | Individualism | Capitalism
Vaccine syringe

Amesh Adalja on the Pandemic in the U.S. and Around the World

In this episode of New Ideal Live, Agustina Vergara Cid interviews Amesh Adalja, a well-known expert on pandemic preparedness, about the fight against the pandemic in the U.S. and around the world.

Among the topics covered:

  • Evidence of the safety of the Covid-19 vaccines available in the U.S.;
  • Whether reaching “herd immunity” is relevant to ending the current pandemic;
  • What explains the recent CDC guidelines about masks;
  • “Breakthrough infections” among the already vaccinated;
  • Covid outbreaks overseas and U.S. measures to help contain them;
  • Recent and upcoming developments with vaccines;
  • The story of the development of mRNA vaccines;
  • Whether travel bans help prevent the spread of viruses like Covid;
  • Lessons from South Korea’s and Taiwan’s approaches to the pandemic;
  • How to evaluate medical experts.

Mentioned in the discussion are Amesh Adalja’s recent article “With vaccinations on the rise, Covid-19 testing takes on a new role” and Onkar Ghate’s white paper, “A Pro-Freedom Approach to Infectious Disease.”

This podcast was recorded on May 19, 2021. Listen to the discussion below. Listen and subscribe from your mobile device on Apple PodcastsGoogle PodcastsSpotify or Stitcher. Watch archived podcasts here.

Podcast audio:

SUPPORT ARI

If you value the ideas presented here, please become an ARI Member today.

Share this article:

Agustina Vergara Cid

Agustina Vergara Cid, LL.B. and LL.M., is a research associate at the Ayn Rand Institute.

Updates from New Ideal

 

Listen to New Ideal Live!

New Ideal Live is the podcast that explores pressing cultural issues from the perspective of Ayn Rand’s philosophy, Objectivism, which upholds the ideals of reason, individualism, and capitalism.

Subscribe here.

Ayn Rand University App

Explore unique philosophical content that challenges conventional views — in courses you can take on the go.

Available on Google Play and
the App Store.